Pacemakers have saved a lot of lives over the years by helping to regulate the heartbeats of those with arrhythmia. The problem, however, is that those pacemakers run on batteries that have a tendency to run out of juice after a while. As a result, patients have to undergo an invasive procedure every once in a while in order to stay alive. By utilizing the technology that allows wristwatches to function, this problem may have finally been addressed.
The researchers responsible for the discovery are Andreas Haeberlin and Adrian Zurbuchen from the University of Bern and the University of Michigan, Futurism reports. The method that the pair proposed basically involves initiating a cycle between the pacemaker and the heart, where the heartbeat will give the pacemaker power via kinetic energy and the pacemaker will give the heart assistance in order to maintain a consistent rhythm.
By setting the system up like this, it creates a loop where the pacemaker is continuously powered and the heartbeat is continuously maintained to have a normal pace. Basically, the researchers just made the heart the battery for the thing that’s keeping it working. A symbiotic relationship, in a sense.
Aside from pacemakers, this discovery could potentially also have an impact on other implanted devices, TechXplore reports. These could include defibrillators or electrical stimulators that keep important organs from ceasing to function. This is a solution that addresses one of the biggest problems involved in implanted devices.
"Repeated battery replacement procedures can be avoided by extending the implants lifespan, which is the goal of energy harvesting concepts,” the Abstract of the paper reads. This reduces the risk of complications for the patient and may even reduce device size. The continuous and powerful contractions of a human heart ideally qualify as a battery substitute."


Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
FDA Approves Mitapivat for Anemia in Thalassemia Patients
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Instagram Outage Disrupts Thousands of U.S. Users
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



